One may therefore speculate that HBO-induced stimulation of insulin sensitivity and mitochondrial function occurs at least partly via mitohormesis (i.e. low-dose ROS-mediated improvement of metabolic pathways) in type 2 diabetes. Here, INS is linked to type 2 diabetes mellitus.